CD3xCD20 bispecific antibody

bispecific antibody targeting CD3 and CD20

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CD3xCD20 bispecific antibody, covering 2026-03-16 to 2026-03-16. Get the full timeline:

Most recent: Clinical Trial Update: Treatment by a Bispecific CD3xCD20 Antibody for Relapse/Refractory Lymphomas After CAR T-cells Therapy [Phase 2]